Compare common side effects, interactions, warnings, and more.
Lexapro
*image for illustrative purpose only
Paxil
*image for illustrative purpose only
Lexapro® (escitalopram) is a selective serotonin reuptake inhibitor (SSRI) used to treat anxiety and depression by increasing available serotonin levels in the brain, which helps improve mood and reduce anxiety. Its FDA-approved indications include the treatment of major depressive disorder (MDD) and generalized anxiety disorder (GAD) in adults and adolescents. Off-label uses may include treating panic disorder, obsessive-compulsive disorder (OCD), and social anxiety disorder. Lexapro is available in tablet and oral solution forms, taken once daily. Common side effects include nausea, insomnia, and sexual dysfunction, and it carries a boxed warning for an increased risk of suicidal thoughts and behaviors in children, adolescents, and young adults, particularly during the initial stages of treatment.
Paxil® (paroxetine) is a selective serotonin reuptake inhibitor (SSRI) used to treat mood disorders by increasing available serotonin levels in the brain, which helps regulate mood and reduce anxiety. Its FDA-approved indications include major depressive disorder (MDD), generalized anxiety disorder (GAD), panic disorder, obsessive-compulsive disorder (OCD), social anxiety disorder, and post-traumatic stress disorder (PTSD). Paxil is available in tablet, extended-release tablet, and oral suspension forms. Common side effects include nausea, drowsiness, and sexual dysfunction, and it carries a boxed warning for an increased risk of suicidal thoughts and behaviors in children, adolescents, and young adults, especially during the initial treatment period.
Selective serotonin reuptake inhibitor (SSRI)
Selective serotonin reuptake inhibitor (SSRI)
Lexapro (escitalopram) is indicated for the:
Treatment of major depressive disorder (MDD) in adults and pediatric patients 12 years of age and older
Treatment of generalized anxiety disorder (GAD) in adults and pediatric patients 7 years and older
Paxil (paroxetine hydrochloride) is indicated in adults for the treatment of:
Major depressive disorder (MDD)
Obsessive compulsive disorder (OCD)
Panic disorder (PD)
Social anxiety disorder (SAD)
Generalized anxiety disorder (GAD)
Posttraumatic stress disorder (PTSD)
Typically taken orally once daily
Comes in 5 mg, 10 mg (scored), and 20 mg (scored) tablets
Typically taken orally once daily
Comes in 10 mg (score), 20 mg (scored), 30 mg, and 40 mg extended-release tablets
Most commonly observed adverse reactions (incidence ≥ 5% and at least twice the incidence of placebo patients) are:
Insomnia
Ejaculation disorder (primarily ejaculatory delay),
Nausea
Sweating increased
Fatigue and sleepiness
Decreased libido
Inability to orgasm
Most common adverse reactions (≥5% and at least twice placebo) are:
Abnormal ejaculation
Weakness
Constipation
Decreased appetite
Diarrhea
Dizziness
Dry mouth
Female genital disorder
Impotence
Infection
Insomnia
Libido decreased
Male genital disorder
Nausea
Nervousness
Sleepiness
Sweating
Tremor
Yawn
Do not use MAOIs intended to treat psychiatric disorders with Lexapro or within 14 days of stopping treatment with Lexapro. Do not use Lexapro within 14 days of stopping an MAOI intended to treat psychiatric disorders. In addition, do not start Lexapro in a patient who is being treated with linezolid or intravenous methylene blue
Concomitant use of pimozide
Known hypersensitivity to escitalopram or citalopram or any of the inactive ingredients
Drug interactions: SSRIs, SNRIs, tryptophan, drugs that affect hemostasis (NSAIDs, aspirin, warfarin)
Concomitant use of monoamine oxidase inhibitors (MAOIs) or use within 14 days of discontinuing a MAOI
Concomitant use of pimozide or thioridazine
Known hypersensitivity to paroxetine or to any of the inactive ingredients in Paxil
Drug interactions: drugs highly bound to plasma protein, drugs metabolized by CYP2D6, tamoxifen
Serotonin syndrome
Discontinuation syndrome
Seizures
Activation of mania/hypomania
Low blood sodium: Can occur in association with syndrome of inappropriate antidiuretic hormone secretion
Increased risk of bleeding
Interference with cognitive and motor performance
Angle closure glaucoma
Use in patients with concomitant illness
Sexual dysfunction
Pregnancy: SSRI use, particularly later in pregnancy, may increase the risk for persistent pulmonary hypertension and symptoms of poor adaptation (respiratory distress, temperature instability, feeding difficulties, hypotonia, tremor, irritability) in the neonate
Serotonin syndrome
Embryofetal and neonatal toxicity
Increased risk of bleeding
Activation of mania/Hhypomania
Seizures
Angle-closure glaucoma
Sexual dysfunction
WARNING: SUICIDAL THOUGHTS AND BEHAVIORS
Increased risk of suicidal thoughts and behavior in pediatric and young adult patients taking antidepressants. Closely monitor all antidepressant-treated patients for clinical worsening and emergence of suicidal thoughts and behaviors. Lexapro is not approved for use in pediatric patients less than 7 years of age.
WARNING: SUICIDAL THOUGHTS AND BEHAVIORS
Increased risk of suicidal thoughts and behavior in pediatric and young adult patients taking antidepressants. Closely monitor all antidepressant treated patients for clinical worsening and emergence of suicidal thoughts and behaviors. Paxil is not approved for use in pediatric patients.
*This information is from the label for brand name Lexapro®. See the Full Prescribing Information for more complete information. Escitalopram, the active ingredient in Lexapro, may also be the active ingredient in other medications, and this information may not be accurate for all medications that include the active ingredient escitalopram.
*This information is from the label for brand name Paxil®. See the Full Prescribing Information for more complete information. Paroxetine, the active ingredient in Paxil, may also be the active ingredient in other medications, and this information may not be accurate for all medications that include the active ingredient paroxetine.
The information provided here is NOT MEDICAL ADVICE and is for informational and educational purposes only. The drug comparison tool does not determine eligibility for medications or treatments provided via the Hims/Hers platform. Consultation with a healthcare provider is required to assess suitability for any medical treatment based on individual health and medical history. All product names and associated trademarks are the property of their respective owners.